Status:
COMPLETED
Pharmacokinetics Evaluation of Vitamin D Formulations
Lead Sponsor:
Factors Group of Nutritional Companies Inc.
Conditions:
Vitamin D
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The primary objective of this study is to evaluate plasma concentrations of Vitamin D (25-hydroxyvitamin D; 1,25-dihydroxyvitamin D) of different Vitamin D formulations in healthy volunteers at two co...
Detailed Description
Study Design: At least 40 healthy volunteers of both sexes in the age range 21-65 participate in a parallel, randomized blinded study conducted with different vitamin D3 products. Each treatment is ...
Eligibility Criteria
Inclusion
- age between 21 and 65 years; avoid consumption of any additional food supplements containing vitamin D; avoid use of tanning beds or other artificial UVB sources.
- Participants must complete an online questionnaire on their medical history, weight, height, lifestyle (smoking, exercising etc.) and dietary habits relating to food rich in vitamin D, including other dietary supplementations.
Exclusion
- use of vitamin D, calcium, magnesium, fish oil, or omega 3 fatty acids supplements; history of acute or chronic illness (such as gastrointestinal, liver and kidney disorders, osteoporosis …); pregnancy or lactation.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT05209425
Start Date
January 1 2022
End Date
April 30 2023
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Natural Factors
Coquitlam, British Columbia, Canada, V3K 6Y2